Vertex Pharmaceuticals
VRTX
#128
Rank
NZ$224.95 B
Marketcap
$876.04
Share price
-0.34%
Change (1 day)
25.80%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): NZ$0.56 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$11.02 Billion. a decrease over its 2023 earnings that were of NZ$7.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.48 B-93.69%
2023 NZ$7.73 B3.19%
2022 NZ$7.49 B53.56%
2021 NZ$4.88 B-12.06%
2020 NZ$5.55 B118.45%
2019 NZ$2.54 B120.64%
2018 NZ$1.15 B1473.64%
2017 NZ$73.21 M197.6%
2016 NZ$24.6 M-102.97%
2015 -NZ$0.83 Billion-28.46%
2014 -NZ$1.16 Billion-51.5%
2013 -NZ$2.39 Billion-30584.68%
2012 NZ$7.83 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.04 Billion
2007 -NZ$0.73 Billion83.1%
2006 -NZ$0.4 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.25 Billion-38.16%
2003 -NZ$0.39 Billion
2000 -NZ$66.54 Million-20.38%
1999 -NZ$83.57 Million31.62%
1998 -NZ$63.5 Million91.05%
1997 -NZ$33.24 Million-36.24%
1996 -NZ$52.13 Million12.45%
1995 -NZ$46.36 Million27.4%
1994 -NZ$36.39 Million-1833.33%
1993 NZ$2.09 M-112.12%
1992 -NZ$17.32 Million175%
1991 -NZ$6.3 Million-12.2%
1990 -NZ$7.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$1.20 B 147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.49 B 1,231.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.09 B 7,498.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.66 Billion-3,102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.50 B 6,149.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 Billion-134.76%๐Ÿ‡บ๐Ÿ‡ธ USA